Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price rose 14.7% during trading on Friday . The company traded as high as C$0.20 and last traded at C$0.20. Approximately 615,500 shares were traded during mid-day trading, an increase of 49% from the average daily volume of 411,916 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Price Performance
The stock has a market capitalization of C$26.50 million, a P/E ratio of -19.00 and a beta of 0.32. The company’s 50 day simple moving average is C$0.09 and its two-hundred day simple moving average is C$0.07. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- 3 REITs to Buy and Hold for the Long Term
- Bloom Energy: Powering the Future With Decentralized Energy
- Insider Trades May Not Tell You What You Think
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- ESG Stocks, What Investors Should Know
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
